NCT03954847

Brief Summary

The investigators will evaluate the utility of computer aided image analysis in lung cancer with the aim of predicting treatment response and prognosis.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
1,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2012

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2012

Completed
7.4 years until next milestone

First Submitted

Initial submission to the registry

May 16, 2019

Completed
1 day until next milestone

First Posted

Study publicly available on registry

May 17, 2019

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2020

Completed
Last Updated

May 17, 2019

Status Verified

May 1, 2019

Enrollment Period

9 years

First QC Date

May 16, 2019

Last Update Submit

May 16, 2019

Conditions

Lung Cancer

Keywords

Lung cancerImageTreatment responsePrognosisRadiomicDeep learning

Outcome Measures

Primary Outcomes (1)

  • Overall survival

    The interval between the date of diagnosis and death

    2012-2021

Secondary Outcomes (1)

  • Progression free survival

    2012-2021

Study Arms (1)

Lung cancer patients

Lung cancer patients with PET/CT or CT examination before any cancer-specific treatment

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Lung cancer patients with PET/CT or CT examination before any cancer-specific treatment

You may qualify if:

  • Patients \>= 18 years old
  • Pathological diagnosis of NSCLC between 2012 and 2019;
  • PET/CT or CT examination before any cancer-specific treatment;

You may not qualify if:

  • A time interval between treatment and image examination greater than 1 month;
  • A history of other malignancies

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Wuhan, Hubei, 430000, China

RECRUITING

MeSH Terms

Conditions

Lung Neoplasms

Condition Hierarchy (Ancestors)

Respiratory Tract NeoplasmsThoracic NeoplasmsNeoplasms by SiteNeoplasmsLung DiseasesRespiratory Tract Diseases

Central Study Contacts

Yang Jin, MD

CONTACT

027-85755457whuhjy@126.com

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

May 16, 2019

First Posted

May 17, 2019

Study Start

January 1, 2012

Primary Completion

December 31, 2020

Study Completion

December 31, 2020

Last Updated

May 17, 2019

Record last verified: 2019-05

Locations

CN(1)